Update: drug therapy for acute myocardial infarction.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Acute myocardial infarction is potentially a highly treatable disease. Immediate interventions are directed to decreasing tissue hypoxia with oxygen and improving bloodflow to ischemic myocardium using nitrates and thrombolytic agents. Cardiac workload should be reduced by eliminating endogenous catecholamine release with analgesia and sedation, and beta blockade in patients without CHF to decrease heart rate and myocardial oxygen demand. Treatment of the complications of AMI include dysrhythmia prophylaxis, monitoring and specific therapy. Treatment of pump failure includes using vasodilators, vasopressors and positive inotropic agents. Early recognition and timely initiation of appropriate therapy should be every physician's goal.

Original languageEnglish (US)
Pages (from-to)45-50
Number of pages6
JournalComprehensive Therapy
Volume17
Issue number5
StatePublished - May 1991

Fingerprint

Myocardial Infarction
Drug Therapy
Oxygen
Fibrinolytic Agents
Workload
Treatment Failure
Vasodilator Agents
Nitrates
Analgesia
Catecholamines
Myocardium
Therapeutics
Heart Rate
Physicians
Hypoxia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Update : drug therapy for acute myocardial infarction. / Brown, J. F.; Valenzuela, Terence D.

In: Comprehensive Therapy, Vol. 17, No. 5, 05.1991, p. 45-50.

Research output: Contribution to journalArticle

@article{66a12f4d393e47a5859605f9381579e3,
title = "Update: drug therapy for acute myocardial infarction.",
abstract = "Acute myocardial infarction is potentially a highly treatable disease. Immediate interventions are directed to decreasing tissue hypoxia with oxygen and improving bloodflow to ischemic myocardium using nitrates and thrombolytic agents. Cardiac workload should be reduced by eliminating endogenous catecholamine release with analgesia and sedation, and beta blockade in patients without CHF to decrease heart rate and myocardial oxygen demand. Treatment of the complications of AMI include dysrhythmia prophylaxis, monitoring and specific therapy. Treatment of pump failure includes using vasodilators, vasopressors and positive inotropic agents. Early recognition and timely initiation of appropriate therapy should be every physician's goal.",
author = "Brown, {J. F.} and Valenzuela, {Terence D}",
year = "1991",
month = "5",
language = "English (US)",
volume = "17",
pages = "45--50",
journal = "Comprehensive Therapy",
issn = "0098-8243",
publisher = "Humana Press",
number = "5",

}

TY - JOUR

T1 - Update

T2 - drug therapy for acute myocardial infarction.

AU - Brown, J. F.

AU - Valenzuela, Terence D

PY - 1991/5

Y1 - 1991/5

N2 - Acute myocardial infarction is potentially a highly treatable disease. Immediate interventions are directed to decreasing tissue hypoxia with oxygen and improving bloodflow to ischemic myocardium using nitrates and thrombolytic agents. Cardiac workload should be reduced by eliminating endogenous catecholamine release with analgesia and sedation, and beta blockade in patients without CHF to decrease heart rate and myocardial oxygen demand. Treatment of the complications of AMI include dysrhythmia prophylaxis, monitoring and specific therapy. Treatment of pump failure includes using vasodilators, vasopressors and positive inotropic agents. Early recognition and timely initiation of appropriate therapy should be every physician's goal.

AB - Acute myocardial infarction is potentially a highly treatable disease. Immediate interventions are directed to decreasing tissue hypoxia with oxygen and improving bloodflow to ischemic myocardium using nitrates and thrombolytic agents. Cardiac workload should be reduced by eliminating endogenous catecholamine release with analgesia and sedation, and beta blockade in patients without CHF to decrease heart rate and myocardial oxygen demand. Treatment of the complications of AMI include dysrhythmia prophylaxis, monitoring and specific therapy. Treatment of pump failure includes using vasodilators, vasopressors and positive inotropic agents. Early recognition and timely initiation of appropriate therapy should be every physician's goal.

UR - http://www.scopus.com/inward/record.url?scp=0026161613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026161613&partnerID=8YFLogxK

M3 - Article

C2 - 1879127

AN - SCOPUS:0026161613

VL - 17

SP - 45

EP - 50

JO - Comprehensive Therapy

JF - Comprehensive Therapy

SN - 0098-8243

IS - 5

ER -